PCPI and Members Applaud Quality Measure Alignment Provisions in Transparency Executive Order
Tuesday, July 9, 2019
Posted by: Katie Keenan
While health care price disclosure grabbed most of the headlines, the Trump administration’s June 24 executive order also includes two measures that could significantly change quality measurement. These are a Health Quality Roadmap consolidating quality measures used by federal health programs, and easing access to de-identified claims data for measure development.
“Functional health care markets require quality information just as much as price information. If anything, quality transparency is more important because it is better care, not lower prices, that truly improves patients’ lives,” says PCPI CEO Kevin Donnelly.
The order gives federal officials six months to develop the Roadmap, which is intended to align quality measures and data reporting across Medicare, Medicaid, the Children’s Health Insurance Program, the Health Insurance Marketplace, the Military Health System, and the Veterans Affairs Health System. It will include a strategy for developing common quality measurements; aligning inpatient and outpatient measures; and eliminating low-value or counterproductive measures.
In the same timeframe, federal health programs must increase access to de-identified claims data for use by researchers, innovators, providers, and entrepreneurs. A list of priority datasets that will strengthen market transparency and function will also be developed.
Several PCPI members lauded the new quality initiatives:
PCPI’s Donnelly also lauds the order as an opportunity to advocate for better patient care.
“As the nation’s leading developer of clinician-level quality measures, PCPI is acutely aware of the need for measures that are robust, uniform and efficient for use across diverse patient groups and clinical settings. This executive order is an invitation to collaborate for better patient care that we and our members will accept through our organized advocacy efforts.”